Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Progenra and Tokyo Medical University begin rheumatoid arthritis collaboration

Oct. 24, 2011

Dynavax and GSK add new target in Toll-like receptor inhibitor program

Oct. 24, 2011

Merck Serono to return full rights to Parkinson's disease candidate to Newron

Oct. 21, 2011

Evotec and Apeiron Biologics collaborate on new target

Oct. 21, 2011

Ligand Pharmaceuticals and Sage Therapeutics enter licensing agreement

Oct. 21, 2011

Syntaxin and Ipsen enter new global discovery and development collaboration

Oct. 20, 2011

Servier and Miragen enter research partnership for microRNA-targeted drugs

Oct. 20, 2011

Almirall and Lundbeck enter agreement to copromote escitalopram

Oct. 19, 2011

ULURU to out-license European rights to Altrazeal

Oct. 18, 2011

Ube and Santen form prostanoid EP2 receptor agonist collaboration

Oct. 18, 2011

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...